Eric Jackson - Amgen President

AMG Stock  EUR 265.20  0.35  0.13%   

President

Mr. Eric E. Jackson is Member of the Management Board, Chief Operating Officer of AMG Advanced Metallurgical Group NV. He has served in various senior capacities for businesses now owned by AMG since 1998. Mr. Jackson previously acted as Director at Phibro, a division of Salomon, Inc, and as VicePresident at Louis Dreyfus Corporationrationration. In addition, from 1979 to 1989 he acted in various roles for Cargill Incorporated in Canada and the United States since 2011.
Age 67
Tenure 13 years
Jackson received a BS degree in Economics and a Masters of Business Administration, both from the University of Saskatchewan, Canada.

Similar Executives

Found 4 records

PRESIDENT Age

John HuttAmeriprise Financial
48
Joseph SweeneyAmeriprise Financial
62
Alicia CharityAmeriprise Financial
N/A
Walter BermanAmeriprise Financial
80
Amgen Inc (AMG) is traded on Berlin Exchange in Germany and employs 20 people.

Amgen Inc Leadership Team

Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jackson Dunckel, Member of the Management Board, Chief Financial Officer
Michele Fischer, Vice President IR Contact Officer
Heinz Schimmelbusch, Chairman of the Management Board, Chief Executive Officer
Dagmar Bottenbruch, Independent Member of the Supervisory Board
Eric Jackson, Member of the Management Board and Presidentident of the AMG Processing Division, COO
Donatella Ceccarelli, Independent Member of the Supervisory Board
Willem Hassel, Independent Vice Chairman of the Supervisory Board
Frank Lohner, Independent Member of the Supervisory Board
Herbert Depp, Independent Member of the Supervisory Board
Steve Hanke, Independent Chairman of the Supervisory Board

Amgen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Amgen Stock

When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.